mSILSC: Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer

Sponsor
Ruijin Hospital (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03633539
Collaborator
Changhai Hospital (Other), Fudan University (Other), RenJi Hospital (Other)
0
1
2
64
0

Study Details

Study Description

Brief Summary

This study is designed to evaluate the short-term and long-term results after single incision laparoscopic surgery for colorectal cancer(SILSC) compared with conventional laparoscopic surgery for colorectal cancer(CLSC).

Condition or Disease Intervention/Treatment Phase
  • Procedure: Single-incision Laparoscopic Surgery
  • Procedure: Conventional Laparoscopic Surgery
N/A

Detailed Description

In order to improve cosmetic effect and reduce postoperative pain, single-incision laparoscopic surgery (SILS) is attracting increasing attention. SILS is considered to be the next major advance in the progress of minimally invasive surgical approaches to colorectal disease that is more feasible in generalized use. In most previous studies, SILS for colorectal cancer was feasible and short-term safe compared to conventional laparoscopic surgery (CLS) . However, there is still controversy over its potential better cosmetic effect and less postoperative pain. Moreover, the long-term oncologic outcomes are still inconclusive as only a few studies showed long-term survival data. Up to now, most studies were limited to their retrospective nature and small samples. So more studies, especially large-scale, randomized controlled trials are needed to establish the best indications for SILS for colorectal cancer.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Multi-center Prospective Randomized Controlled Study of the Single-incision Laparoscopic Surgery Versus Conventional Laparoscopic Surgery for Colorectal Cancer
Anticipated Study Start Date :
Aug 1, 2020
Anticipated Primary Completion Date :
Dec 1, 2020
Anticipated Study Completion Date :
Dec 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Conventional Laparoscopic Surgery

Patients with colorectal cancer undergo conventional laparoscopic surgery(multi-ports).

Procedure: Conventional Laparoscopic Surgery
Patients undergo conventional laparoscopic surgery. In this group,the surgery is performed through 3-5 ports according to the surgeons habits and specific conditions.
Other Names:
  • CLSC
  • Experimental: Single-incision Laparoscopic Surgery

    Patients with colorectal cancer undergo single-incision laparoscopic surgery.

    Procedure: Single-incision Laparoscopic Surgery
    Patients undergo single-incision laparoscopic surgery. In this group,the surgery is performed through a transumbilical port. The surgeon will adjust surgical position to expose the operative field with the help of gravity. Besides,hand over hand cross and parallel techniques are needed to achieve the SILS. All the other operative procedures are the same as conventional laparoscopic surgery.
    Other Names:
  • SILSC
  • Outcome Measures

    Primary Outcome Measures

    1. Postoperative complications [30 days after surgery]

      Postoperative complications rate 30 days after surgery

    Secondary Outcome Measures

    1. Operative time [intraoperative]

      Operative time(minutes)

    2. Intraoperative blood loss [intraoperative]

      Estimated blood loss(milliliters,ml)

    3. Incision length [intraoperative]

      Incision length(centimeters,cm)

    4. Lymph node detection [14 days after surgery]

      Lymph nodes harvested(numbers)

    5. Incisal margin [14 days after surgery]

      Length of proximal and distal margin (centimeters,cm)

    6. Tumor size [14 days after surgery]

      The diameter of tumors(centimeters,cm)

    7. Length of stay [1-14 days after surgery]

      Duration of hospital stay(days after surgery)

    8. Postoperative recovery course [1-14 days after surgery]

      Time to first ambulation, flatus, liquid diet and soft diet (hours after surgery)

    9. Pain score [1-3 days after surgery]

      Postoperative pain is recorded using the visual analog scale (VAS) pain score (0-10 points)tool on postoperative day 1, 2, 3 and the day of discharge

    10. 3-year disease free survival rate [36 months after surgery]

      3-year disease free survival rate

    11. 5-year overall survival rate [60 months after surgery]

      5-year overall survival rate

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Inclusion Criteria:

    • 18 years < age ≤85 years

    • Tumor located in colon and high rectum ( the lower border of the tumor is above the peritoneal reflection)

    • Pathological colorectal carcinoma

    • Clinically diagnosed cT1-4aN0-2 M0 lesions according to the 8th Edition of AJCC Cancer Staging Manual

    • Tumor size of 5 cm or less

    • ECOG score is 0-1

    • ASA score is Ⅰ-Ⅲ

    • Informed consent

    Exclusion Criteria:
    • Body mass index (BMI) >35 kg/m2

    • The lower border of the tumor is located distal to the peritoneal reflection

    • Pregnant woman or lactating woman

    • Severe mental disease

    • Previous abdominal surgery(except appendectomy and cholecystotomy)

    • Emergency operation due to complication (bleeding, perforation or obstruction) caused by colorectal cancer

    • Requirement of simultaneous surgery for other disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ruijin Hospital North Shanghai China 201801

    Sponsors and Collaborators

    • Ruijin Hospital
    • Changhai Hospital
    • Fudan University
    • RenJi Hospital

    Investigators

    • Study Chair: Kun Liu, MD, Ruijin Hospitla North

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Zhao Ren, Chief Physicion, Ruijin Hospital
    ClinicalTrials.gov Identifier:
    NCT03633539
    Other Study ID Numbers:
    • RJ-mSILSC-2018
    First Posted:
    Aug 16, 2018
    Last Update Posted:
    Sep 10, 2021
    Last Verified:
    Sep 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Zhao Ren, Chief Physicion, Ruijin Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 10, 2021